2616
COM:CSTONEPHARMA
CStone Pharmaceuticals Co Ltd
- Stock
Last Close
1.96
25/11 03:32
Market Cap
1.57B
Beta: -
Volume Today
1.52M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|
average inventory | 30.68M - | 41.78M 36.16% | 65.51M 56.81% | ||||||
average payables | 151K - | 2.43M 1,509.60% | 20.93M 761.20% | 32.67M 56.07% | 30.53M 6.55% | 161.72M 429.76% | 268.40M 65.96% | ||
average receivables | 38.57M - | ||||||||
book value per share | 0.72 - | 0.43 40.18% | 0.52 20.87% | 2.86 446.74% | 2.82 1.35% | 1.04 63.32% | 0.38 63.02% | 0.36 5.59% | |
capex per share | -0.00 - | -0.01 1,025.27% | -0.01 36.82% | -0.01 49.75% | -0.07 467.69% | -0.13 87.39% | -0.09 32.17% | -0.05 40.68% | |
capex to depreciation | -16.12 - | -15.24 5.43% | -1.50 90.15% | -0.90 40.02% | -4.83 436.04% | -6.58 36.34% | -2.29 65.26% | -1.12 51.10% | |
capex to operating cash flow | 0.01 - | 0.05 897.93% | 0.01 80.82% | 0.01 3.45% | 0.14 1,357.36% | 0.10 28.54% | 0.17 65.43% | 0.11 33.55% | |
capex to revenue | -0.07 - | -0.61 789.74% | -0.21 65.43% | -0.14 33.70% | |||||
cash per share | 0.83 - | 0.55 33.78% | 1.58 189.75% | 3.16 99.87% | 3.24 2.52% | 1.48 54.33% | 0.89 40.03% | 0.81 8.52% | |
days of inventory on hand | 209.65 - | 39.90 80.97% | 248.97 524.02% | ||||||
days payables outstanding | 42.38 - | 112.83 166.24% | 522.21 362.83% | 563.64 7.93% | |||||
days sales outstanding | |||||||||
debt to assets | 0.00 - | 0.02 1,413.81% | 0.08 244.11% | 0.17 127.85% | 0.22 25.15% | ||||
debt to equity | 0.00 - | 0.03 1,521.48% | 0.14 408.47% | 0.64 341.48% | 0.80 24.87% | ||||
dividend yield | |||||||||
earnings yield | -0.02 - | -0.03 35.64% | -0.16 437.63% | -0.38 142.39% | -0.14 64.21% | -0.25 83.92% | -0.20 21.18% | -0.14 28.40% | |
enterprise value | 11.27B - | 10.40B 7.71% | 10.32B 0.81% | 6.84B 33.70% | 5.94B 13.19% | 7.30B 22.87% | 4.57B 37.35% | 1.94B 57.52% | |
enterprise value over ebitda | -45.58 - | -38.87 14.71% | -11.26 71.03% | -4.42 60.77% | -4.92 11.34% | -3.99 18.94% | -5.80 45.54% | -4.08 29.75% | |
ev to operating cash flow | -52.92 - | -43.31 18.15% | -13.04 69.89% | -6.33 51.47% | -11.69 84.65% | -4.92 57.93% | -7.46 51.79% | -3.30 55.81% | |
ev to sales | 5.72 - | 29.94 423.74% | 9.50 68.28% | 4.19 55.91% | |||||
free cash flow per share | -0.22 - | -0.26 18.02% | -0.81 216.19% | -1.26 55.05% | -0.55 55.99% | -1.40 152.99% | -0.61 56.55% | -0.52 15.00% | |
free cash flow yield | -0.02 - | -0.02 27.53% | -0.07 200.88% | -0.14 88.99% | -0.07 52.37% | -0.21 218.15% | -0.15 28.98% | -0.25 72.17% | |
graham net net | 0.76 - | 0.43 43.61% | 0.45 3.94% | 2.62 485.10% | 2.47 5.78% | 0.59 75.95% | -0.12 119.50% | -0.10 15.23% | |
graham number | 2.02 - | 1.75 13.35% | 4.57 161.33% | 15.07 229.73% | 8.61 42.89% | 6.31 26.76% | 2.66 57.77% | 1.54 42.23% | |
income quality | 0.84 - | 0.70 16.70% | 0.44 37.08% | 0.47 6.11% | 0.42 11.12% | 0.77 85.74% | 0.68 12.21% | 1.60 136.32% | |
intangibles to total assets | 0.00 - | 0.00 3,511.34% | 0.00 39.70% | 0.00 19.53% | 0.00 291.12% | 0.03 1,695.22% | 0.10 213.87% | 0.10 6.82% | |
interest coverage | -1.09K - | -4.04K 269.95% | -5.15K - | -925.83 82.02% | -826.38 10.74% | -98.18 88.12% | -45.23 53.93% | ||
interest debt per share | 0.00 - | 0.00 75.00% | 0.01 - | 0.08 1,418.79% | 0.15 85.95% | 0.25 65.98% | 0.30 18.21% | ||
inventory turnover | 1.74 - | 9.15 425.47% | 1.47 83.97% | ||||||
invested capital | 0.00 - | 0.03 1,521.48% | 0.14 408.47% | 0.64 341.48% | 0.80 24.87% | ||||
market cap | 11.33B - | 10.49B 7.46% | 11.02B 5.09% | 7.96B 27.74% | 8.88B 11.51% | 7.86B 11.42% | 4.84B 38.42% | 2.58B 46.83% | |
net current asset value | 765.63M - | 432.03M 43.57% | 488.16M 12.99% | 2.42B 395.28% | 2.76B 14.32% | 893.20M 67.68% | 57.82M 93.53% | 124.62M 115.54% | |
net debt to ebitda | 0.24 - | 0.31 29.43% | 0.77 145.63% | 0.72 5.32% | 2.44 236.13% | 0.31 87.25% | 0.35 11.31% | 1.33 284.37% | |
net income per share | -0.25 - | -0.31 25.52% | -1.77 464.99% | -3.53 98.86% | -1.17 66.93% | -1.71 46.26% | -0.82 51.78% | -0.29 64.65% | |
operating cash flow per share | -0.22 - | -0.24 12.76% | -0.80 229.37% | -1.25 55.10% | -0.49 61.05% | -1.27 162.22% | -0.52 59.00% | -0.47 10.73% | |
payables turnover | 8.61 - | 3.23 62.44% | 0.70 78.39% | 0.65 7.35% | |||||
receivables turnover | |||||||||
research and ddevelopement to revenue | 1.35 - | 5.35 295.98% | 1.28 76.17% | 1.14 10.82% | |||||
return on tangible assets | -0.30 - | -0.55 83.85% | -1.07 95.37% | -1.04 3.13% | -0.32 68.67% | -0.90 178.05% | -0.65 27.76% | -0.25 62.19% | |
revenue per share | 0.99 - | 0.21 78.94% | 0.41 96.22% | 0.37 10.52% | |||||
roe | -0.35 - | -0.72 109.83% | -3.39 367.42% | -1.23 63.63% | -0.41 66.48% | -1.65 298.78% | -2.15 30.38% | -0.80 62.55% | |
roic | -0.38 - | -0.47 23.87% | -1.21 158.40% | -0.83 31.66% | -0.40 51.98% | -1.36 241.71% | -1.12 17.75% | -0.65 41.79% | |
sales general and administrative to revenue | 0.08 - | 0.45 436.68% | 0.13 70.71% | 0.11 19.97% | |||||
shareholders equity per share | 0.72 - | 0.43 40.18% | 0.52 20.87% | 2.86 446.74% | 2.82 1.35% | 1.04 63.32% | 0.38 63.02% | 0.36 5.59% | |
stock based compensation to revenue | 0.34 - | 0.91 166.59% | 0.30 67.70% | 0.08 72.98% | |||||
tangible asset value | 766.95M - | 450.83M 41.22% | 514.43M 14.11% | 2.48B 382.14% | 2.95B 18.86% | 1.14B 61.45% | 289.63M 74.52% | 283.79M 2.02% | |
tangible book value per share | 0.78 - | 0.46 41.22% | 0.52 14.11% | 2.86 447.40% | 2.82 1.52% | 0.98 65.39% | 0.25 74.68% | 0.22 9.02% | |
working capital | 765.63M - | 432.03M 43.57% | 495.73M 14.74% | 2.43B 389.96% | 2.85B 17.14% | 1.02B 63.99% | 300.44M 70.68% | 479.45M 59.58% |
All numbers in (except ratios and percentages)